Immunization is an important tool to fight diseases caused by viral, bacterial or fungal pathogenes. The invention provides a new approach for the generation of oligomeric vaccines. The underlying principle is the high affinity interaction between S-protein and a modified S-tag of bovine pancreatic RNase A which is applied to hemagglutinin (H5). The technology can be applied to produce high molecular vaccines. They have many advantages compared to recently used vaccines including high immunogenicity, high stability, short production time and lower production costs. The approach could therefore be used for the immunization of livestock.
Further information: PDF
ESA Patentverwertungsagentur Sachsen-Anhalt GmbH
Phone: +49 (0)391/8 10 72 20
Dr. Detlef Förster
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
All latest news from the category: Technology Offerings
Nanofiber-hydrogel loaded with stem cells shows success
… treating severe complication of Crohn’s disease. Johns Hopkins researchers develop injectable biomimetic hydrogel composite that promotes regenerative healing in an animal model of Crohn’s perianal fistulas. In a new…
World-class center for single crystal electron diffraction will be UK first
New electron diffraction equipment is about to revolutionize how we understand crystal structures. A new centre based jointly at the University of Southampton and the University of Warwick will draw…
Research challenges “sugar hypothesis” of diabetic cataract development
In preclinical models, investigators uncovered a novel mechanism underlying the development of diabetic cataracts that undermines current hypothesis. New findings from investigators at Brigham and Women’s Hospital, a founding member…